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for label-free protein detection, exploiting as sensing unit surface-immobilized antibodies or aptamers. Here we report two Electrolyte-Gated OFETs biosensors for IL-6 detection, featuring monoclonal antibodies and peptide aptamers adsorbed at the gate. Both strategies yield biosensors that can work on a wide range of IL-6 concentrations and exhibit a remarkable Limit of Detection of 1pM. Eventually, EGOFETs responses have been used to extract and compare the binding thermodynamics between the sensing moiety, immobilized at the gate electrode, and IL-6.
I. INTRODUCTION
Interleukin (IL)-6 is a pleiotropic cytokine with context-dependent pro-and antiinflammatory properties. 1 It is a small glycoprotein produced by a broad variety of cell types, including cells of the innate and adaptive immune system as well as nonleukocytes, in response to several stimuli, particularly representing tissue damage or stress. 2 IL-6 is a multifunctional cytokine that orchestrates innate and adaptive immunity, induces the acute phase response, and is involved in bone metabolism by acting on osteoclasts and promoting osteoclastogenesis, as well as in the control of vascular permeability by inducing the production of vascular endothelial growth factor. 2 It represents a critical cytokine in infection, cancer and inflammation, and it has been demonstrated that increased IL-6 levels are associated with disease settings such as several chronic inflammatory pathologies and cancer, in contrast to the relative low (1) (2) (3) (4) (5) pg/mL) physiological concentrations found in human serum. 1 Moreover, increased levels of circulating IL-6 are commonly used as indicator of inflammaging. 3 Besides serving as a biomarker for inflammation processes, IL-6 is now being targeted by therapeutic strategies to inhibit its pathway.
ELISA and western blotting are currently the state-of-the-art techniques for detecting IL-6 in bodily fluids, 4,5 since these techniques can provide a sensitivity in the sub pg/ml range of concentration. 6 Nevertheless, both techniques are time consuming, expensive and require bulky equipment, making them difficult to transfer at the point-ofcare (POC). Electrochemical sensors based on polyelectrolyte nanoparticles loaded with ferrocene molecules can also provide good sensitivity (units of pg/ml), but they need sophisticated procedures. 6, 7 The last years have witnessed a large number of studies attempting at developing label-free biosensors alternative to currently used platforms based on optical response. [8] [9] [10] [11] [12] [13] [14] [15] As for IL-6, the latest reported biosensors that allow for a real-time monitoring of the cytokine levels without requiring secondary [33] [34] [35] [36] [37] .
Here, we describe two EGOFET-based biosensors for detection of IL-6 with functionalized gate, one based on immobilized monoclonal Abs, and the other featuring immobilized peptide aptamers (Affimers). Both devices exhibit a Limit of Detection (LOD) as low as 1 pM, which corresponds to 20 pg/mL, i.e. falling in the physiological range of IL-6 levels in solution. Moreover, the devices respond across four orders of magnitude. Our configuration allows us to investigate the thermodynamics of the biorecognition events between the cytokine and its immobilized partner. We find that the particular monoclonal Ab and Affimer used in the present paper exhibit comparable affinity for IL-6, although differences in the electrostatic contributions to the free energy of binding will be described.
II. EXPERIMENTAL

A. Device Fabrication
The used Test Patterns (TPs) (1 cm 2 total area) were purchased from "Fondazione 
C. Electrical Characterization
Electrical measurements were performed in a buffer solution (PBS 50 mM, pH 7.4, We then obtained the LOD as the concentration corresponding to a signal S that is mean ± Affimers are directly immobilized on the gold surface by means of the His-tag.
III. RESULTS AND DISCUSSION
EGOFET-based immunobiosensors (i.e. featuring immobilized monoclonal Ab) and peptide aptasensor (with Affimer adsorbed on the gate electrode) were prepared as can be expressed as:
where W and L are the channel width and length, respectively, μ is the charge carrier mobility, CG is the capacitance of the gate dielectric, and VDS is the drain voltage. 38 Please note that the transconductance depends on fixed values, as the channel geometry and VDS, and on the μCG product, which instead can be affected by binding events at the gate electrode.
FIG. 2. Transfer characteristics of EGOFET biosensors upon exposure to different
concentrations of IL-6 in PBS buffer: curves corresponding to Antibody-based biosensor Such trends allow us to infer hypotheses on the mechanism of coupling between the binding of the antigen and the carriers in the organic semiconductive channel. The negative shift of Vth suggests that upon IL-6 binding there is an increase in the number of traps to charge carriers, while it is difficult to unambiguously assign the change in gm solely to mobility or capacitance changes. Nevertheless, panels e) and f) in Figure 2 provide evidence for the multi-parametric nature of EGOFET response, and indicate the transconductance as a solid observable, alternative to the current response, to monitor binding process. A limit of detection of 1 pM was calculated for both Antibody-and
Affimer-based biosensors. The dose curves were then fitted with a Langmuir model. Langmuir model can be used to describe the equilibrium binding of IL-6 to the gate electrodes, and therefore to extract the affinity constant Ka. We obtain the following values from the dose curves in Fig. 2 : Ka,Ab = 9.1  7.0 10 9 for the interaction between the surface immobilized Ab and IL-6, while we get Ka,Aff 6.9  3.4 10 9 for the Affimer/IL-6 couple. We can therefore state that, within the assumptions underlying the use of the simple Langmuir model and its applicability to the complex bio-inorganic interfaces used here, 41 the surface-bound antibody and Affimer used here display comparable affinity for IL-6. This is in line with the same calculated LOD value and comparable sensitivity, as shown by the dose curves, for the two corresponding devices.
Thermodynamics of biorecognition
The dose curves displayed in Fig. 2c and Fig. 2d were obtained by plotting the device response S at a fixed gate voltage value VGS = -0.8 V. We have recently demonstrated 15 that the EGOFET response is modulated by the gate voltage value. It is apparent that the current variation upon exposure of the device to the same IL-6 solution is much higher when the device is operated at the VGS values in the sub-threshold regime:
as VGS becomes more negative, the highest change in the IDS current observed upon IL-6 binding, Smax, decreases significantly. Very importantly, fitting the dose curves obtained at different gate voltages, the affinity constant at the EGOFET surface Ka turns out to be dependent on VGS. For both Antibody-and Affimer-biosensors Ka may decrease by up to one order of magnitude, as VGS is shifted from the sub-threshold regime (VGS =-0.3/-0.4 V) to the accumulation regime (VGS =-0.7/-0.8 V). Qualitatively, such trend is observed for both kinds of devices; to gain more insights into the molecular determinants to such changes in affinity, one can follow the approach that we recently proposed 15 to compare the molar electrostatic free energy upon binding, ΔGe, for the interaction of Antibody and
Affimer with IL-6. In particular, since the binding constant can be factorized as follows:
expanding the (enthalpic part of) molar electrostatic free energy ΔGe at the second order leads to the following equation:
Substituting eq. 3 in eq. 2 leads to: One can obtain the charge contribution to the electrostatic free energy by multiplying The capacitance contribution Cm,eff is always negative (stabilizing the binding) for both couples. The charge contribution Qm,eff is higher in magnitude for the interaction between IL-6 and the Antibody, and its variation in the investigated VGS range is more marked than that of its counterpart concerning the Affimer.
a) b)
The sign and magnitude of the electrostatics contribution provide an explanation for the dependence of Ka as a function of VGS. For the Antibody, Ka is 7.9 10 9 at VGS= -0.4V, 9.1 10 9 at VGS= -0.8V and its minimum value is reached at VGS= -0.6V (4.0 10 9 ). For the Affimer, Ka is 1.3 10 10 at VGS= -0.4V, and decreases to 6.9 10 9 at VGS= -0.8V, as shown in Fig. 3 . One more interesting consideration can be drawn when calculating the ratio between the best fit values for Qm,eff (-13.5kC mol -1 and -10.9kC mol -1 for Antibody and Affimer, respectively) and the Faraday constant. Such ratio is about 0.14 and 0.11 for Ab and Affimer, respectively, thus suggesting that binding does not lead to net charge transfer between the two biomolecules, rather only a partial charge rearrangement takes place. Therefore, we can safely infer that most of the Qm,eff contribution arises from the change of dipole moment at the interface.
IV. SUMMARY AND CONCLUSIONS
In this paper, we demonstrated two EGOFET-based biosensors for inflammatory cytokine IL-6, differing with respect to the biomolecule immobilized at the gate electrode to be the core sensing unit of the device. In one case, Antibodies to IL-6 were used to functionalize the gate electrode, while the second kind of device relies on the use of surface-bound Affimers. Both sensors exhibit LOD as low as 1pM, which is lower than the increased levels of IL-6 in the serum of patients suffering from inflammatory response to a range of pathologies, therefore, the EGOFET biosensors described here represent a valid label-free alternative to state-of-the-art platforms for the quantification for this biomarker.
The gate voltage VGS affects the device response by modulating the affinity constant Ka between IL-6 and its surface-bound partner, by modulating the electrostatic contributions to the free energy of binding. This means that EGOFETs might be used as a tool to investigate the thermodynamics of binding between two biomolecules.
Moreover, the modulation of VGS can be used as an experimental handle to enhance the sensitivity of the biosensor, and bias the recognition events in the presence of interfering agents.
